Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00787670 · ClinicalTrials.gov registry record · NA
Impact of GBS on CVD in Type 2 Diabetes Mellitus
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT00787670 is a NA study that has completed, run by Duke University. The registered enrollment target is 84 participants.
The verdict
NCT00787670, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
This research is a NIH single site study with the aims to (1) determine whether surgically induced weight loss decreases the risk of CVD in morbidly obese subjects with T2DM. (2) elucidate the mechanisms by which surgically induced weight loss reduces over time the risk of CVD in morbidly obsess subjects with T2DM. Study'subjects will be enrolled from obese individuals with type 2 diabetes (T2DM). The study includes two groups, subjects undergoing gastric bypass surgery and a control group not undergoing weight loss surgery. A total of 60 subjects (30 in each group) will be recruited. Basal, 6 and 12 months assessments will include: insulin sensitivity determination, cardiovascular function by echo doppler, and DEXA scan. This study involves risk-level II procedures, however, the risks inherent to the gastric bypass surgery are not considered study-derived because subjects are enrolled from individuals that have already decided to have this surgery. We will determine protein expression profiles of inflammation-related adipokines in the subcutaneous and intra-abdominal adipose tissues of morbidly obese subjects with T2DM before and after surgically induced weight loss.
Interventions
- PROCEDURE gastric bypass surgery
- OTHER Diabetes Support and Education
- OTHER Tissue Control Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00787670
The ClinicalTrials.gov registry entry for NCT00787670 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which gastric bypass surgery is the first listed.
NCT00787670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00787670 about?
NCT00787670 is a clinical study titled "Impact of GBS on CVD in Type 2 Diabetes Mellitus". This research is a NIH single site study with the aims to (1) determine whether surgically induced weight loss decreases the risk of CVD in morbidly obese subjects with T2DM. (2) elucidate the mechanisms by which surgically induced weight loss reduces over time the risk of CVD in morbidly obsess sub...
What is the current status of trial NCT00787670?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2008-11. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00787670?
The interventions under investigation include: gastric bypass surgery (PROCEDURE), Diabetes Support and Education (OTHER), Tissue Control Group (OTHER).
Who is sponsoring clinical trial NCT00787670?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.